We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

69 hedge funds and large institutions have $899M invested in SpringWorks Therapeutics in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 4

41% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 17

21% more funds holding

Funds holding: 5769 (+12)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

2.83% more ownership

Funds ownership: 74.35%77.17% (+2.8%)

27% less capital invested

Capital invested by funds: $1.23B → $899M (-$334M)

Holders
69
Holders Change
+12
Holders Change %
+21.05%
% of All Funds
1.52%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
16
Increased
24
Reduced
17
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$4.34M +$946K +29,016 +22%
Northern Trust
27
Northern Trust
Illinois
$3.82M +$295K +9,059 +7%
Ameriprise
28
Ameriprise
Minnesota
$3.61M -$1.22M -37,336 -22%
TG
29
TCW Group
California
$3.31M +$4M +122,758 New
CIBC Asset Management
30
CIBC Asset Management
Ontario, Canada
$3M +$3.63M +111,266 New
AA
31
ALPS Advisors
Colorado
$2.11M -$275K -8,420 -10%
Millennium Management
32
Millennium Management
New York
$1.64M +$1.79M +55,037 +962%
Charles Schwab
33
Charles Schwab
California
$1.63M +$42.8K +1,313 +2%
N
34
Nuveen
North Carolina
$1.15M +$179K +5,502 +15%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.06M +$430K +13,179 +51%
ECM
36
ExodusPoint Capital Management
New York
$837K +$1.01M +30,996 New
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$540K +$381K +11,700 +141%
Prudential Financial
38
Prudential Financial
New Jersey
$491K -$3.26K -100 -0.5%
PPA
39
Parametric Portfolio Associates
Washington
$454K +$19.4K +596 +4%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$435K +$525K +16,100 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$419K -$13.6K -417 -3%
Renaissance Technologies
42
Renaissance Technologies
New York
$410K +$496K +15,200 New
AC
43
Athanor Capital
New York
$386K -$528K -16,206 -53%
SIM
44
Spark Investment Management
New York
$351K +$134K +4,100 +46%
VEA
45
Virtus ETF Advisers
New York
$336K -$58.8K -1,805 -13%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$331K +$92.1K +2,826 +30%
AllianceBernstein
47
AllianceBernstein
Tennessee
$300K +$362K +11,100 New
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$271K +$327K +10,021 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$254K
Ensign Peak Advisors
50
Ensign Peak Advisors
Utah
$254K +$307K +9,403 New

SWTX Hedge Fund Activity: Q1 2020 in Review

69 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2020, worth a combined $899M — down 27% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new SWTX positions and 4 closed out — a net gain of 12 holders — while 24 added to existing stakes and 17 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $18.6M. The largest seller was BVF Inc, cutting an estimated $10.2M.

  • 69 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2020, up from 57 in Q4 2019.
  • Funds reported $899M of SpringWorks Therapeutics stock for Q1 2020, down 27% quarter-over-quarter.
  • 16 funds opened new SpringWorks Therapeutics positions in Q1 2020 and 4 closed out, a net change of +12 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2020 was Point72 Asset Management, an estimated $18.6M added.
  • The largest SpringWorks Therapeutics seller in Q1 2020 was BVF Inc, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2020.